Sort
51,593 grants matching “hepatitis”
Correlates of protective immunity to HCV and rational vaccine design: Project 2
$737,505Arash Grakoui · Emory University · U19 · FY2021 · AI
Dietary Fat and HDL Metabolism
$737,485Frank M Sacks · Harvard School Of Public Health · R01 · FY2012 · HL
The Impact of HCV Infection on Bone Turnover, Density, and Strength
$737,374Todd T Brown · Johns Hopkins University · R01 · FY2018 · AI
Gut Flora Metabolism of Dietary Phosphatidylcholine and CVD
$737,321Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2017 · HL
Gut Flora Metabolism of Dietary Phosphatidylcholine and CVD
$737,321Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2015 · HL
Gut Flora Metabolism of Dietary Phosphatidylcholine and CVD
$737,321Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2016 · HL
Gut Flora Metabolism of Dietary Phosphatidylcholine and CVD
$737,321Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2019 · HL
Inflammation, Macrophage Differentiation, and Cancer
$737,020Zheng-Gang Liu · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
The Impact of HCV Treatment in HIV/HCV coinfected and HCV monoinfected Incarcerated Persons on HCV Elimination
$736,715Risha Irvin · Johns Hopkins University · R01 · FY2024 · DA
Novel Pathogen Associated Cancers (PQ12)
$736,412Denise A. Galloway · Fred Hutchinson Cancer Research Center · R01 · FY2013 · CA
Enhancement of Two Key Research Programs within the Sylvester Cancer Center
$736,405W Jarrard Goodwin · University Of Miami School Of Medicine · P30 · FY2009 · CA
Toxicogenomics of Hepatotoxicity in Monkeys
$736,277Matthew S Lawrence · Virscio, Inc. · R44 · FY2006 · DK
The National Drug Abuse Treatment Clinical Trials Network
$736,265Walter Nmn Ling · University Of California Los Angeles · U10 · FY2011 · DA
Cell-specific nanocarrier with endocytic and endosomolytic activities for therapeutic genome editing
$736,158Kit S Lam · University Of California At Davis · UG3 · FY2019 · TR
Behavioral Assessment and Medical (BAM) Core
$736,134Robert Kernachan Heaton · University Of California, San Diego · P50 · FY2018 · DA
Behavioral Assessment and Medical (BAM) Core
$736,134Robert Kernachan Heaton · University Of California, San Diego · P50 · FY2017 · DA
Them1-Mediated Metabolic Regulation and Pathogenic Role in NAFLD
$736,103David E Cohen · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · DK
Predicting the causative SNPs in LD blocks by allele-specific structural analysis
$736,100Alain T Laederach · Univ Of North Carolina Chapel Hill · R01 · FY2016 · HG
TRANSFORM - Transforming the evidence base on estimating prevalence of opioid use disorder and expanded access to interventions to prevent drug related deaths: an international data linkage study
$736,072Louisa Degenhardt · University Of New South Wales · R01 · FY2025 · DA
Liver Cirrhosis Network: Longitudinal and Clinical Trial Studies
$735,995Mandana Khalili · University Of California, San Francisco · U01 · FY2023 · DK
Plant-derived vaccines against hepatitis C Cooperative *
$735,946Charles Joel Arntzen · Arizona State University-Tempe Campus · U19 · FY2009 · AI
Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant: The TEST Trial
$735,946Marina Serper · University Of Pennsylvania · R01 · FY2022 · DK
Rural Comorbidity and HIV consequences of Opioid use Research and Treatment Initiative (Rural cohort)
$735,865Heidi M. Crane · University Of Washington · U24 · FY2019 · DA
Natural History, Therapy and Pathogenesis of Chronic Viral Hepatitis B
$735,739Marc Ghany · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2010 · DK
Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes
$735,632Gabriel Quantum Shaibi · Arizona State University-Tempe Campus · U01 · FY2025 · DK